Estrogen and Progesterone Market Report

China Estrogen and Progesterone Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：207
  • REPORT CODE：GMM1823681
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Estrogen and Progesterone industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Abbott Healthcare Products BV

    • Orion Corporation

    • Jenapharm GmbH & Co KG

    • FIS-FABBRICA ITALIANA SINTETICI SpA

    • Bayer Oy

    • AstraZeneca UK Limited

    • Pfizer Healthcare Ireland

    • Gedeon Richter Plc

    • NVOrganon

    • MERCK SERONO LIMITED

    • Aspen Pharmacare Australia Pty Ltd

    • DrKade Pharmazeutische Fabrik GmbH

    • Novartis Pharma Schweiz AG

    By Type:

    • Ulipristal Acetate

    • Asoprisnil

    • Telapristone

    • Aglepristone

    • Mifepristone

    By Application:

    • Pharmacy

    • Department of Endocrinology

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Estrogen and Progesterone Market Overview 2018-2029

    • 1.1 China Estrogen and Progesterone Industry Development Overview

    • 1.2 China Estrogen and Progesterone Industry Development History

    • 1.3 China Estrogen and Progesterone Industry Market Size (2018-2029)

    • 1.4 China Estrogen and Progesterone Market Analysis by Type from Production Side

      • 1.4.1 China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Ulipristal Acetate (2018-2029)

      • 1.4.2 China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Asoprisnil (2018-2029)

      • 1.4.3 China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Telapristone (2018-2029)

      • 1.4.4 China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Aglepristone (2018-2029)

      • 1.4.5 China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Mifepristone (2018-2029)

    • 1.5 China Estrogen and Progesterone Market Analysis by Application from Consumption End

      • 1.5.1 China Estrogen and Progesterone Sales Volume, Sales Value and Growth Rate of Pharmacy (2018-2029)

      • 1.5.2 China Estrogen and Progesterone Sales Volume, Sales Value and Growth Rate of Department of Endocrinology (2018-2029)

      • 1.5.3 China Estrogen and Progesterone Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Estrogen and Progesterone Market Analysis by Region

      • 1.6.1 North China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

    Chapter 2 China Estrogen and Progesterone Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Estrogen and Progesterone Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Estrogen and Progesterone Market Status and Competition Analysis in 2023

      • 2.2.3 China Estrogen and Progesterone Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Estrogen and Progesterone Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Estrogen and Progesterone Industry Development

    Chapter 3 Estrogen and ProgesteroneIndustry Chain Analysis

    • 3.1 Estrogen and Progesterone Industry Chain

    • 3.2 Estrogen and Progesterone Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Estrogen and Progesterone Market

    • 3.3 Estrogen and Progesterone Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Estrogen and Progesterone Market

    Chapter 4 China Estrogen and Progesterone Market, by Type

    • 4.1 China Estrogen and Progesterone Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Estrogen and Progesterone Total Production Volume and Growth Rate from Production Side

    • 4.5 China Estrogen and Progesterone Production Volume and Growth Rate, by Type

      • 4.5.1 China Estrogen and Progesterone Production Volume and Growth Rate of Ulipristal Acetate

      • 4.5.2 China Estrogen and Progesterone Production Volume and Growth Rate of Asoprisnil

      • 4.5.3 China Estrogen and Progesterone Production Volume and Growth Rate of Telapristone

      • 4.5.4 China Estrogen and Progesterone Production Volume and Growth Rate of Aglepristone

      • 4.5.5 China Estrogen and Progesterone Production Volume and Growth Rate of Mifepristone

    Chapter 5 China Estrogen and Progesterone Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Estrogen and Progesterone Total Market Size and Growth Rate from Consumption End

    • 5.5 China Estrogen and Progesterone Market Size and Growth Rate, by Application

      • 5.5.1 China Estrogen and Progesterone Market Size and Growth Rate of Pharmacy

      • 5.5.2 China Estrogen and Progesterone Market Size and Growth Rate of Department of Endocrinology

      • 5.5.3 China Estrogen and Progesterone Market Size and Growth Rate of Hospital

    Chapter 6 China Estrogen and Progesterone Market, by Region

    • 6.1 China Estrogen and Progesterone Production Volume and Production Value, by Region

    • 6.2 China Estrogen and Progesterone Sales Volume and Sales Value, by Region

    Chapter 7 North China Estrogen and Progesterone Market Analysis

    • 7.1 North China Estrogen and Progesterone Market, by Type

    • 7.2 North China Estrogen and Progesterone Market, by Application

    Chapter 8 Central China Estrogen and Progesterone Market Analysis

    • 8.1 Central China Estrogen and Progesterone Market, by Type

    • 8.2 Central China Estrogen and Progesterone Market, by Application

    Chapter 9 South China Estrogen and Progesterone Market Analysis

    • 9.1 South China Estrogen and Progesterone Market, by Type

    • 9.2 South China Estrogen and Progesterone Market, by Application

    Chapter 10 East China Estrogen and Progesterone Market Analysis

    • 10.1 East China Estrogen and Progesterone Market, by Type

    • 10.2 East China Estrogen and Progesterone Market, by Application

    Chapter 11 Northeast China Estrogen and Progesterone Market Analysis

    • 11.1 Northeast China Estrogen and Progesterone Market, by Type

    • 11.2 Northeast China Estrogen and Progesterone Market, by Application

    Chapter 12 Southwest China Estrogen and Progesterone Market Analysis

    • 12.1 Southwest China Estrogen and Progesterone Market, by Type

    • 12.2 Southwest China Estrogen and Progesterone Market, by Application

    Chapter 13 Northwest China Estrogen and Progesterone Market Analysis

    • 13.1 Northwest China Estrogen and Progesterone Market, by Type

    • 13.2 Northwest China Estrogen and Progesterone Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Abbott Healthcare Products BV

        • 14.1.1 Abbott Healthcare Products BV Company Profile

        • 14.1.2 Abbott Healthcare Products BV Estrogen and Progesterone Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Orion Corporation

        • 14.2.1 Orion Corporation Company Profile

        • 14.2.2 Orion Corporation Estrogen and Progesterone Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Jenapharm GmbH & Co KG

        • 14.3.1 Jenapharm GmbH & Co KG Company Profile

        • 14.3.2 Jenapharm GmbH & Co KG Estrogen and Progesterone Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 FIS-FABBRICA ITALIANA SINTETICI SpA

        • 14.4.1 FIS-FABBRICA ITALIANA SINTETICI SpA Company Profile

        • 14.4.2 FIS-FABBRICA ITALIANA SINTETICI SpA Estrogen and Progesterone Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bayer Oy

        • 14.5.1 Bayer Oy Company Profile

        • 14.5.2 Bayer Oy Estrogen and Progesterone Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 AstraZeneca UK Limited

        • 14.6.1 AstraZeneca UK Limited Company Profile

        • 14.6.2 AstraZeneca UK Limited Estrogen and Progesterone Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer Healthcare Ireland

        • 14.7.1 Pfizer Healthcare Ireland Company Profile

        • 14.7.2 Pfizer Healthcare Ireland Estrogen and Progesterone Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Gedeon Richter Plc

        • 14.8.1 Gedeon Richter Plc Company Profile

        • 14.8.2 Gedeon Richter Plc Estrogen and Progesterone Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 NVOrganon

        • 14.9.1 NVOrganon Company Profile

        • 14.9.2 NVOrganon Estrogen and Progesterone Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 MERCK SERONO LIMITED

        • 14.10.1 MERCK SERONO LIMITED Company Profile

        • 14.10.2 MERCK SERONO LIMITED Estrogen and Progesterone Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Aspen Pharmacare Australia Pty Ltd

        • 14.11.1 Aspen Pharmacare Australia Pty Ltd Company Profile

        • 14.11.2 Aspen Pharmacare Australia Pty Ltd Estrogen and Progesterone Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 DrKade Pharmazeutische Fabrik GmbH

        • 14.12.1 DrKade Pharmazeutische Fabrik GmbH Company Profile

        • 14.12.2 DrKade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Novartis Pharma Schweiz AG

        • 14.13.1 Novartis Pharma Schweiz AG Company Profile

        • 14.13.2 Novartis Pharma Schweiz AG Estrogen and Progesterone Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Estrogen and Progesterone Industry Research Conclusions

    • 15.2 Estrogen and Progesterone Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Estrogen and Progesterone Industry Market Size (2018-2029)

    • Figure China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Ulipristal Acetate (2018-2029)

    • Figure China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Asoprisnil (2018-2029)

    • Figure China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Telapristone (2018-2029)

    • Figure China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Aglepristone (2018-2029)

    • Figure China Estrogen and Progesterone Production Volume, Production Value and Growth Rate of Mifepristone (2018-2029)

    • Figure China Estrogen and Progesterone Sales Volume, Sales Value and Growth Rate of Pharmacy (2018-2029)

    • Figure China Estrogen and Progesterone Sales Volume, Sales Value and Growth Rate of Department of Endocrinology (2018-2029)

    • Figure China Estrogen and Progesterone Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

    • Figure Central China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

    • Figure South China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

    • Figure East China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Estrogen and Progesterone Market Size and Growth Rate from 2018-2029

    • Figure Estrogen and Progesterone Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Estrogen and Progesterone Market Share by Type in 2018

    • Figure China Estrogen and Progesterone Market Share by Type in 2023

    • Figure China Estrogen and Progesterone Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Estrogen and Progesterone Production Volume and Growth Rate of Ulipristal Acetate (2018-2023)

    • Figure China Estrogen and Progesterone Production Volume and Growth Rate of Asoprisnil (2018-2023)

    • Figure China Estrogen and Progesterone Production Volume and Growth Rate of Telapristone (2018-2023)

    • Figure China Estrogen and Progesterone Production Volume and Growth Rate of Aglepristone (2018-2023)

    • Figure China Estrogen and Progesterone Production Volume and Growth Rate of Mifepristone (2018-2023)

    • Figure China Estrogen and Progesterone Market Share by Application in 2018

    • Figure China Estrogen and Progesterone Market Share by Application in 2023

    • Figure China Estrogen and Progesterone Total Market Size and Growth Rate from Consumption End

    • Figure China Estrogen and Progesterone Market Size and Growth Rate of Pharmacy (2018-2023)

    • Figure China Estrogen and Progesterone Market Size and Growth Rate of Department of Endocrinology (2018-2023)

    • Figure China Estrogen and Progesterone Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Estrogen and Progesterone Production Volume by Region (2018-2023)

    • Table China Estrogen and Progesterone Production Volume Share by Region (2018-2023)

    • Figure China Estrogen and Progesterone Production Volume Share by Region (2018-2023)

    • Table China Estrogen and Progesterone Production Value by Region (2018-2023)

    • Table China Estrogen and Progesterone Production Value Share by Region (2018-2023)

    • Figure China Estrogen and Progesterone Production Value Share by Region (2018-2023)

    • Table China Estrogen and Progesterone Sales Volume by Region (2018-2023)

    • Table China Estrogen and Progesterone Sales Volume Share by Region (2018-2023)

    • Figure China Estrogen and Progesterone Sales Volume Share by Region (2018-2023)

    • Table China Estrogen and Progesterone Sales Value by Region (2018-2023)

    • Table China Estrogen and Progesterone Sales Value Share by Region (2018-2023)

    • Figure China Estrogen and Progesterone Sales Value Share by Region (2018-2023)

    • Table North China Estrogen and Progesterone Production Volume by Type (2018-2023)

    • Table North China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Figure North China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Table North China Estrogen and Progesterone Sales Volume by Application (2018-2023)

    • Table North China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Figure North China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Table Central China Estrogen and Progesterone Production Volume by Type (2018-2023)

    • Table Central China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Figure Central China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Table Central China Estrogen and Progesterone Sales Volume by Application (2018-2023)

    • Table Central China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Figure Central China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Table South China Estrogen and Progesterone Production Volume by Type (2018-2023)

    • Table South China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Figure South China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Table South China Estrogen and Progesterone Sales Volume by Application (2018-2023)

    • Table South China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Figure South China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Table East China Estrogen and Progesterone Production Volume by Type (2018-2023)

    • Table East China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Figure East China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Table East China Estrogen and Progesterone Sales Volume by Application (2018-2023)

    • Table East China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Figure East China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Table Northeast China Estrogen and Progesterone Production Volume by Type (2018-2023)

    • Table Northeast China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Figure Northeast China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Table Northeast China Estrogen and Progesterone Sales Volume by Application (2018-2023)

    • Table Northeast China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Table Southwest China Estrogen and Progesterone Production Volume by Type (2018-2023)

    • Table Southwest China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Figure Southwest China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Table Southwest China Estrogen and Progesterone Sales Volume by Application (2018-2023)

    • Table Southwest China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Table Northwest China Estrogen and Progesterone Production Volume by Type (2018-2023)

    • Table Northwest China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Figure Northwest China Estrogen and Progesterone Production Volume Share by Type (2018-2023)

    • Table Northwest China Estrogen and Progesterone Sales Volume by Application (2018-2023)

    • Table Northwest China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Estrogen and Progesterone Sales Volume Share by Application (2018-2023)

    • Table Abbott Healthcare Products BV Company Profile

    • Table Abbott Healthcare Products BV Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table Orion Corporation Company Profile

    • Table Orion Corporation Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table Jenapharm GmbH & Co KG Company Profile

    • Table Jenapharm GmbH & Co KG Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table FIS-FABBRICA ITALIANA SINTETICI SpA Company Profile

    • Table FIS-FABBRICA ITALIANA SINTETICI SpA Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table Bayer Oy Company Profile

    • Table Bayer Oy Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca UK Limited Company Profile

    • Table AstraZeneca UK Limited Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table Pfizer Healthcare Ireland Company Profile

    • Table Pfizer Healthcare Ireland Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table Gedeon Richter Plc Company Profile

    • Table Gedeon Richter Plc Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table NVOrganon Company Profile

    • Table NVOrganon Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table MERCK SERONO LIMITED Company Profile

    • Table MERCK SERONO LIMITED Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table Aspen Pharmacare Australia Pty Ltd Company Profile

    • Table Aspen Pharmacare Australia Pty Ltd Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table DrKade Pharmazeutische Fabrik GmbH Company Profile

    • Table DrKade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Revenue, Price and Gross (2018-2023)

    • Table Novartis Pharma Schweiz AG Company Profile

    • Table Novartis Pharma Schweiz AG Estrogen and Progesterone Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US